Hengkang Medical Group Co Ltd (002219) - Total Assets
Based on the latest financial reports, Hengkang Medical Group Co Ltd (002219) holds total assets worth CN¥6.55 Billion CNY (≈ $958.98 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See Hengkang Medical Group Co Ltd shareholders equity for net asset value and shareholders' equity analysis.
Hengkang Medical Group Co Ltd - Total Assets Trend (2004–2024)
This chart illustrates how Hengkang Medical Group Co Ltd's total assets have evolved over time, based on quarterly financial data.
Hengkang Medical Group Co Ltd - Asset Composition Analysis
Current Asset Composition (December 2024)
Hengkang Medical Group Co Ltd's total assets of CN¥6.55 Billion consist of 30.3% current assets and 69.7% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 7.1% |
| Accounts Receivable | CN¥1.31 Billion | 19.7% |
| Inventory | CN¥202.35 Million | 3.0% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥405.91 Million | 6.1% |
| Goodwill | CN¥1.11 Billion | 16.7% |
Asset Composition Trend (2004–2024)
This chart illustrates how Hengkang Medical Group Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market value of Hengkang Medical Group Co Ltd.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Hengkang Medical Group Co Ltd's current assets represent 30.3% of total assets in 2024, a decrease from 72.7% in 2004.
- Cash Position: Cash and equivalents constituted 7.1% of total assets in 2024, up from 3.9% in 2004.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 22.0% of total assets, an increase from 0.0% in 2004.
- Asset Diversification: The largest asset category is accounts receivable at 19.7% of total assets.
Hengkang Medical Group Co Ltd Competitors by Total Assets
Key competitors of Hengkang Medical Group Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Sanbo Hospital Management Group Ltd. A
SHE:301293
|
China | CN¥3.72 Billion |
|
WELL Health Technologies Corp
TO:WELL
|
Canada | CA$2.02 Billion |
|
Hospital Mater Dei S.A
SA:MATD3
|
Brazil | R$4.40 Billion |
|
MEDICLIN Aktiengesellschaft
XETRA:MED
|
Germany | €879.69 Million |
|
Ramsay Health Care Ltd
AU:RHC
|
Australia | AU$22.48 Billion |
|
Regis Healthcare Ltd
AU:REG
|
Australia | AU$2.11 Billion |
|
Oceania Healthcare Ltd
AU:OCA
|
Australia | AU$3.01 Billion |
|
Pacific Smiles Group Ltd
AU:PSQ
|
Australia | AU$163.53 Million |
Hengkang Medical Group Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.56 | 0.64 | 0.29 |
| Quick Ratio | 0.50 | 0.57 | 0.25 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥-1.48 Billion | CN¥-1.13 Billion | CN¥-2.89 Billion |
Hengkang Medical Group Co Ltd - Advanced Valuation Insights
This section examines the relationship between Hengkang Medical Group Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 4.30 |
| Latest Market Cap to Assets Ratio | 0.17 |
| Asset Growth Rate (YoY) | 9.8% |
| Total Assets | CN¥6.68 Billion |
| Market Capitalization | $1.15 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Hengkang Medical Group Co Ltd's assets below their book value (0.17x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Hengkang Medical Group Co Ltd's assets grew by 9.8% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Hengkang Medical Group Co Ltd (2004–2024)
The table below shows the annual total assets of Hengkang Medical Group Co Ltd from 2004 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥6.68 Billion ≈ $977.08 Million |
+9.82% |
| 2023-12-31 | CN¥6.08 Billion ≈ $889.73 Million |
+7.76% |
| 2022-12-31 | CN¥5.64 Billion ≈ $825.62 Million |
-15.67% |
| 2021-12-31 | CN¥6.69 Billion ≈ $978.99 Million |
+38.78% |
| 2020-12-31 | CN¥4.82 Billion ≈ $705.43 Million |
-1.81% |
| 2019-12-31 | CN¥4.91 Billion ≈ $718.47 Million |
-43.94% |
| 2018-12-31 | CN¥8.76 Billion ≈ $1.28 Billion |
-14.57% |
| 2017-12-31 | CN¥10.25 Billion ≈ $1.50 Billion |
+71.32% |
| 2016-12-31 | CN¥5.98 Billion ≈ $875.75 Million |
+25.19% |
| 2015-12-31 | CN¥4.78 Billion ≈ $699.52 Million |
+152.74% |
| 2014-12-31 | CN¥1.89 Billion ≈ $276.77 Million |
+65.46% |
| 2013-12-31 | CN¥1.14 Billion ≈ $167.27 Million |
+31.53% |
| 2012-12-31 | CN¥869.10 Million ≈ $127.18 Million |
+44.66% |
| 2011-12-31 | CN¥600.80 Million ≈ $87.92 Million |
+17.03% |
| 2010-12-31 | CN¥513.36 Million ≈ $75.12 Million |
+13.47% |
| 2009-12-31 | CN¥452.43 Million ≈ $66.20 Million |
+26.06% |
| 2008-12-31 | CN¥358.91 Million ≈ $52.52 Million |
+51.81% |
| 2007-12-31 | CN¥236.42 Million ≈ $34.60 Million |
+26.22% |
| 2006-12-31 | CN¥187.31 Million ≈ $27.41 Million |
+18.81% |
| 2005-12-31 | CN¥157.66 Million ≈ $23.07 Million |
+3.03% |
| 2004-12-31 | CN¥153.01 Million ≈ $22.39 Million |
-- |
About Hengkang Medical Group Co Ltd
New Journey Health Technology Group Co.,LTD, together with its subsidiaries, provides medical services and pharmaceuticals products in China and internationally. The company operates regional medical centers to treat aging diseases, such as tumors, cardiovascular, cerebrovascular, and orthopedics. It is also involved in the research, development, production, and sale of medicines comprising Duyiw… Read more